Artemis Medicare Services Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings
- October 9, 2026
- Posted by: Neeraj Pandey
- Category: Market
Artemis Medicare Services share price Rs 311.15 (9 October 2026). Base target Rs 370, bull Rs 443, downside risk Rs 247. PE 42.84. 52W range Rs 203.35 to Rs 378.80.
Quick Answer
The Artemis Medicare Services share price target for 2027 is Rs 370, about 18.9% above the current price of Rs 311.15. The bull case is Rs 443, and the downside risk level, which is not a target, is Rs 247. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 36.3%, with the stock holding its PE of 42.84. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing an Artemis Medicare Services target price for 2027 should start with where the stock sits today. At Rs 311.15 on 9 October 2026, it is 17.9% below its 52-week high of Rs 378.80 and 53.0% above its 52-week low of Rs 203.35. That range spans 86% from low to high, so the entry point matters as much as the Artemis Medicare Services price forecast itself.
This article builds the Artemis Medicare Services share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 370 base case and the Rs 443 bull case were reached, along with a downside risk level of Rs 247.
Click Here – Get Free Investment Predictions
Artemis Medicare Services Stock Analysis: Company Overview and Key Stats
Artemis Medicare Services (NSE: ARTEMISMED) has a market capitalisation of Rs 4,883 crore. In FY26 it reported revenue of Rs 1,111 crore and net profit of Rs 103.72 crore. The table collects the figures the Artemis Medicare Services share price target is built on.
| Metric | Value |
|---|---|
| Company | Artemis Medicare Services |
| NSE Ticker | ARTEMISMED |
| CMP (9 October 2026) | Rs 311.15 |
| 52-Week High | Rs 378.80 |
| 52-Week Low | Rs 203.35 |
| Market Cap | Rs 4,883 crore |
| PE Ratio (TTM) | 42.84 |
| Industry PE | 62.79 |
| Price to Book | 5.64 |
| Return on Equity | 11.09% |
| Debt to Equity | 0.28 |
| EPS (TTM) | Rs 7.20 |
| Dividend Yield | 0.15% |
| 12-Month Base Target | Rs 370 |
| Bull Case | Rs 443 |
| Downside Risk Level (not a target) | Rs 247 |
Why Is Artemis Medicare Services Share Price Target Set at Rs 370 for 2027?
The base-case Artemis Medicare Services stock target of Rs 370 applies a PE multiple of 42.84 to a forward EPS estimate of Rs 8.64. That EPS assumes 20.0% yearly growth, the pace from FY24 to FY26, and puts the target 18.9% above the current price. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Artemis Medicare Services Target Price: Five Years of Results
Artemis Medicare Services grew revenue from Rs 558.70 crore in FY22 to Rs 1,111 crore in FY26, a compound annual growth rate of 18.8%. Net profit grew faster, from Rs 31.40 crore to Rs 103.72 crore (34.8% a year), which shows margin gains did part of the work and not just higher sales.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 558.70 | 31.40 | 2.29 | 0.00 |
| FY23 | 744.76 | 38.01 | 2.79 | 0.45 |
| FY24 | 885.93 | 49.14 | 3.53 | 0.45 |
| FY25 | 969.90 | 82.18 | 5.31 | 0.45 |
| FY26 | 1,111.07 | 103.72 | 6.56 | 0.45 |
FY26 revenue growth was 14.6%, slower than the four-year average of 18.8%, and net profit moved up 26.2%. EPS rose from Rs 3.53 in FY24 to Rs 6.56 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Artemis Medicare Services converted 9.3% of FY26 revenue into net profit, against 8.5% in FY25, within a five-year range of 5.1% to 9.3%. EBITDA margin was 19.3% in FY26 versus 19.1% in FY25.
In the June 2026 quarter, revenue was Rs 292.69 crore, up 11.8% from the same quarter a year earlier, while net profit of Rs 31.44 crore was up 48.3%. EBITDA came in at Rs 61.82 crore, up 27.9% year on year. The next quarterly result is the first test of whether the earnings assumption holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.28, and shareholders’ equity grew from Rs 361.26 crore in FY22 to Rs 940.68 crore in FY26. Operating cash flow in FY26 was Rs 131.95 crore against capital expenditure of Rs 104.95 crore, leaving free cash flow of Rs 27.00 crore, or 0.6% of the current market capitalisation. In FY25 free cash flow was Rs 62.55 crore.
Valuation Check for the Artemis Medicare Services Stock Target: PE, Price to Book and ROE
At a PE of 42.84 against an industry PE of 62.79, Artemis Medicare Services trades at a discount to its industry. Price to book is 5.64 on a book value of Rs 54.69 per share, and return on equity is 11.09%. A PE of 42.84 equals an earnings yield of 2.3%, and the FY26 dividend of Rs 0.45 per share gives a yield of 0.15%.
Shareholding Pattern and Institutional Holding
Promoters held 58.39% of Artemis Medicare Services in June 2026, and promoter holding fell from 66.53% in September 2025 to 58.39% in June 2026. Foreign institutional investors (FII) held 12.29% and domestic institutions (DII) held 2.40%, which puts total institutional holding at 14.69%. FII holding rose from 0.37% in September 2025 to 12.29% in June 2026. Public shareholders own the remaining 26.92%.
Artemis Medicare Services Share Price Targets for the Short Term and 12 Months
Short Term Artemis Medicare Services Stock Target Levels: Technical Setup
At Rs 311.15 on 9 October 2026, Artemis Medicare Services trades below its 50-day simple moving average of Rs 326.35 and above its 200-day exponential moving average of Rs 284.69. The 14-day RSI reads 37.3, which is neutral territory, and the MACD line sits below its signal line. The nearest resistance level is Rs 326.35 (50-day simple moving average) and the nearest support is Rs 284.69 (200-day exponential moving average). A sustained move above Rs 326.35 would improve the short-term setup, while a close below Rs 284.69 would shift attention to the next support.
12 Month Artemis Medicare Services Target Price for 2027
The 12-month target for Artemis Medicare Services is Rs 370: forward EPS of Rs 8.64 at a PE of 42.84. That is 18.9% above Rs 311.15. It would still leave the stock 2.3% below its 52-week high of Rs 378.80.
How EPS Growth and PE Multiple Change the Artemis Medicare Services Target Price
| EPS Growth | PE 34.27 | PE 42.84 | PE 49.27 |
|---|---|---|---|
| 0.0% (EPS Rs 7.20) | Rs 247 | Rs 308 | Rs 355 |
| 20.0% (EPS Rs 8.64) | Rs 296 | Rs 370 | Rs 426 |
| 25.0% (EPS Rs 9.00) | Rs 308 | Rs 386 | Rs 443 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Artemis Medicare Services price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Artemis Medicare Services Stock Target in 2027
Bull Case Rs 443
The bull case Artemis Medicare Services price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 9.00, and a PE multiple that rises 15% to 49.27. That gives Rs 443, 42.4% above the current price and above the 52-week high of Rs 378.80, so the stock would have to set a fresh 52-week high.
Downside Risk Level Rs 247
The downside risk level is not a target. It assumes EPS stays flat at Rs 7.20 and the PE falls 20% to 34.27. That gives Rs 247, 20.6% below the current price and above the 52-week low of Rs 203.35.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 25.0% | 49.27 | Rs 443 | +42.4% |
| Base Case | 20.0% | 42.84 | Rs 370 | +18.9% |
| Downside Risk | 0.0% | 34.27 | Rs 247 | -20.6% |
Key Risks to the Artemis Medicare Services Target Price for 2027
Growth Slowdown Risk for the Artemis Medicare Services Price Target
Revenue in the June 2026 quarter was up 11.8% year on year, and FY26 revenue growth was 14.6%. If growth slows from here, the EPS estimate behind the Artemis Medicare Services stock target will need revising.
Liquidity and Size Risk
Artemis Medicare Services has a market capitalisation of Rs 4,883 crore. Institutional holding is 14.69%, and promoters hold 58.39%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.
Valuation and Margin Risk
Net margin was 9.3% in FY26, so a small slip in costs moves profit noticeably. At a PE of 42.84 versus an industry PE of 62.79, a de-rating toward the downside-risk PE of 34.27 would cut the price even if earnings hold.
Market and Technical Risk
The stock trades 17.9% below its 52-week high, with an RSI of 37.3 and a MACD reading below its signal line. Broader market weakness can override company fundamentals in the short term.
How to Invest in Artemis Medicare Services
Start with the live price and volume. Any Artemis Medicare Services share price target is only as current as the data behind it, and the data here is as of 9 October 2026, so refresh the Rs 311.15 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Artemis Medicare Services’ PE, ROE, debt and shareholding in one place.
Check Artemis Medicare Services fundamentals on the Univest Screener
Then compare the three Artemis Medicare Services target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Artemis Medicare Services live price and get daily stock recommendations.
Conclusion
The Artemis Medicare Services share price target for 2027 is Rs 370 in the base case, with Rs 443 as the bull case. The support for that view is arithmetic you can check: EPS grew 36.3% a year over FY24 to FY26, and the stock trades at a PE of 42.84. The risks are equally concrete, including a stock that sits 17.9% below its 52-week high and a downside scenario that cuts the price 21% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Artemis Medicare Services Share Price Target 2027
What is the Artemis Medicare Services share price target for 2027?
Ans. The base-case Artemis Medicare Services share price target for 2027 is Rs 370, with Rs 443 as the bull case. The downside risk level, which is not a target, is Rs 247. These are model estimates from reported earnings and the current PE, not guaranteed outcomes.
What is the Artemis Medicare Services share price today?
Ans. As of 9 October 2026, 12:52 PM IST, Artemis Medicare Services trades at Rs 311.15, up 0.88% on the day. The 52-week range is Rs 203.35 to Rs 378.80.
Is Artemis Medicare Services a buy or sell at the current price?
Ans. The data is mixed rather than one-sided: EPS has grown 36.3% a year over FY24 to FY26, but the stock is 17.9% below its 52-week high. Whether Artemis Medicare Services fits your portfolio depends on your time horizon and risk appetite, so consult a SEBI-registered advisor before investing. This article is not investment advice.
What are the bull case target and downside risk level for Artemis Medicare Services shares?
Ans. The bull case target is Rs 443, which assumes 25.0% EPS growth and a PE of 49.27. The downside risk level is Rs 247, which assumes flat EPS and a PE of 34.27. It marks a risk, not a target.
What are the main risks to the Artemis Medicare Services price target?
Ans. The main risks are slower revenue growth, a small market capitalisation of Rs 4,883 crore, a PE de-rating and short-term weakness in the broader market. Each is covered in the risk section above.
What is the PE ratio of Artemis Medicare Services and how does it compare with the industry?
Ans. The PE ratio of Artemis Medicare Services is 42.84 against an industry PE of 62.79. Price to book is 5.64 and return on equity is 11.09%. The base case in the Artemis Medicare Services price target holds this PE constant.
Who owns Artemis Medicare Services, and what is the promoter holding?
Ans. Promoters held 58.39% of Artemis Medicare Services in June 2026. FII held 12.29%, DII held 2.40% and the public held 26.92%.
What were Artemis Medicare Services’ latest quarterly results?
Ans. In the June 2026 quarter, Artemis Medicare Services reported revenue of Rs 292.69 crore (up 11.8% year on year) and net profit of Rs 31.44 crore (up 48.3%).
